Sunzen Biotech Bhd (0148) — Financial Flexibility Index
Sunzen Biotech Bhd (0148) has a Financial Flexibility Index of 0.22x as of September 2023. Free cash flow of RM3.67 Million (operating CF RM3.58 Million minus capex RM95.00K) represents 0% of total liabilities (RM16.55 Million). Also explore 0148 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sunzen Biotech Bhd Financial Flexibility Index (2016–2023)
Historical Financial Flexibility Index trend for Sunzen Biotech Bhd across 8 annual periods. Check Sunzen Biotech Bhd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sunzen Biotech Bhd (2016–2023)
Year-by-year free cash flow to debt coverage for Sunzen Biotech Bhd. For the full company profile including market capitalisation, see 0148 market cap overview.
| Year | Flexibility Index | Free Cash Flow (MYR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.09x | RM1.83 Million | RM819.39K | RM20.51 Million | ▲ +108.8% |
| 2022 | -1.02x | RM-29.59 Million | RM-32.06 Million | RM29.08 Million | ▼ -123.2% |
| 2021 | -0.46x | RM-13.96 Million | RM-16.36 Million | RM30.61 Million | ▼ -294.8% |
| 2020 | 0.23x | RM8.36 Million | RM7.20 Million | RM35.73 Million | ▲ +223.2% |
| 2019 | -0.19x | RM-7.02 Million | RM-11.05 Million | RM36.96 Million | ▼ -262.3% |
| 2018 | -0.05x | RM-2.13 Million | RM-4.07 Million | RM40.63 Million | ▼ -113.9% |
| 2017 | 0.38x | RM7.44 Million | RM4.02 Million | RM19.70 Million | ▼ -50.8% |
| 2016 | 0.77x | RM6.89 Million | RM256.13K | RM8.98 Million | — |